Biotech Investors: Chiasma Was Just Called One Of The Most 'Compelling Fresh Ideas' In Pharma
August 10, 2015 at 09:52 AM EDT
In a report published Monday, Barclays analyst Douglas D. Tsao initiated coverage of Chiasma Inc (NASDAQ: CHMA) with an Overweight ...